Fortune Venture Capital logo

Fortune Venture Capital

Asia, Guangdong, China, Shenzhen

Description

Fortune Venture Capital, widely recognized as Shenzhen Capital Group Co., Ltd. (SCGC), stands as a cornerstone of China's venture capital landscape, having been established in April 2000 as one of the nation's earliest market-oriented VC firms. Headquartered in Shenzhen, SCGC has evolved into a dominant force, characterized by its extensive capital base and a broad investment mandate that spans the full life cycle of enterprises, from nascent startups to mature, pre-IPO companies.

The firm's investment strategy is highly diversified, targeting a wide array of high-growth sectors critical to China's economic transformation. These include cutting-edge fields such as information technology, new materials, biomedicine, new energy, environmental protection, high-end equipment manufacturing, and modern services. This comprehensive sectoral approach enables SCGC to identify and back innovative companies across various stages of development, contributing significantly to the advancement of strategic emerging industries.

SCGC's operational scale is truly impressive. As of 2023, the firm manages a substantial portfolio across 256 funds, with total assets under management (AUM) exceeding RMB 470 billion, which translates to approximately USD 65 billion. This immense financial capacity underpins their ability to make significant investments. Their active and prolific investment approach has resulted in backing over 1,800 companies, demonstrating their deep market penetration and commitment to fostering entrepreneurial growth.

A key indicator of SCGC's success is its remarkable track record of exits. To date, 271 of their portfolio companies have successfully gone public through initial public offerings (IPOs), solidifying their reputation for identifying and nurturing ventures with high potential for market realization. While specific initial check sizes can vary based on the stage and sector, SCGC typically deploys substantial capital, with first cheques generally ranging from approximately $1 million for early-stage ventures to over $100 million for more mature, growth-stage companies, reflecting their comprehensive investment scope.

Investor Profile

Fortune Venture Capital has backed more than 47 startups, with 24 new investments in the last 12 months alone. The firm has led 17 rounds, about 36% of its total and boasts 45 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Seed rounds (top funding stages).
  • Majority of deals are located in China, United States, United Kingdom.
  • Strong thematic focus on Manufacturing, Biotechnology, Advanced Materials.
  • Led 11 rounds in the past year.
  • Typical check size: $1M – $100M.

Stage Focus

  • Series B (30%)
  • Series A (28%)
  • Seed (15%)
  • Series C (11%)
  • Series Unknown (11%)
  • Series D (4%)
  • Angel (2%)

Country Focus

  • China (94%)
  • United States (2%)
  • United Kingdom (2%)

Industry Focus

  • Manufacturing
  • Biotechnology
  • Advanced Materials
  • Software
  • Medical
  • Industrial Manufacturing
  • Medical Device
  • Biopharma
  • Chemical
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fortune Venture Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Shunwei Capital
Asia, Beijing, China, Beijing
Co-Investments: 3
The Hina Group
North America, California, United States, San Francisco
Co-Investments: 3
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 3
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Shenzhen Capital Group
Asia, Hunan, China, Nanshan
Co-Investments: 2
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 2
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 2

What are some of recent deals done by Fortune Venture Capital?

Elite Robots

Pudong, Shandong, China

Elite Robots is a robotics company that offers automated machinery manufacturing services.

Machinery ManufacturingManufacturingRobotics
Series DMar 25, 2026
Amount Raised: $87,034,727
Haivivi

Shenzhen, Guangdong, China

Haivivi is the children's educational toy consumer brand.

E-CommerceE-Commerce PlatformsToys
Series AMar 23, 2026
Logicbit Technology

Hangzhou, Zhejiang, China

Logic Bit is a developer of large-scale superconducting quantum computing devices.

SeedMar 17, 2026
Senad Technology

Jiading, Shanghai, China

Senad Technology is a software and hardware technology company with machine vision as the core technology.

Information TechnologySaaSSoftware
Series UnknownMar 3, 2026
Amount Raised: $29,071,880
Inspire-Robots

Haidian, Beijing, China

Inspire-Robots is a supplier of robot core components and intelligent operation solutions.

Industrial AutomationManufacturingRobotics
Series CFeb 25, 2026
Spirit AI

Beijing, Beijing, China

Spirit AI builds 'universal brain' for real-world robots.

Artificial Intelligence (AI)InternetRoboticsSoftware
Series AFeb 24, 2026
Amount Raised: $290,006,380
RoboScience

Shenzhen, Guangdong, China

RoboScience is a company focusing on cross-entity universal embodied intelligence technology.

Industrial AutomationMachinery ManufacturingManufacturingRobotics
SeedFeb 12, 2026
Kaiyun

Fengtai, Beijing, China

Kaiyun is focusing on the research, development, sales and related services of industrial basic software - simulation test IDE.

Series BFeb 9, 2026
Yinghansi Power Technology

Shenzhen, Guangdong, China

Yinghansi Power Technology provides research, development, and manufacturing of robotics technology solutions for the automotive industry.

AutomotiveElectric VehicleManufacturingRobotics
Series AJan 29, 2026
Amount Raised: $14,393,667
Dishi Medical

Hangzhou, Zhejiang, China

Dishi Medical is a company that manufactures Ophthalmic Medical Devices and other micro-assisted robots supported by biotechnology.

BiotechnologyManufacturingMedical
Series AJan 19, 2026

Find More Investors Like Fortune Venture Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Fortune Venture Capital | Pipeseed